417 related articles for article (PubMed ID: 27476047)
1. Heterologous Pseudomonas aeruginosa O-antigen delivery using a Salmonella enterica serovar Typhimurium wecA mutant strain.
Bridge DR; Whitmire JM; Makobongo MO; Merrell DS
Int J Med Microbiol; 2016 Nov; 306(7):529-540. PubMed ID: 27476047
[TBL] [Abstract][Full Text] [Related]
2. An enterobacterial common antigen mutant of Salmonella enterica serovar Typhimurium as a vaccine candidate.
Bridge DR; Whitmire JM; Gilbreath JJ; Metcalf ES; Merrell DS
Int J Med Microbiol; 2015 Sep; 305(6):511-22. PubMed ID: 26070977
[TBL] [Abstract][Full Text] [Related]
3. Oral vaccination of BALB/c mice with Salmonella enterica serovar Typhimurium expressing Pseudomonas aeruginosa O antigen promotes increased survival in an acute fatal pneumonia model.
DiGiandomenico A; Rao J; Goldberg JB
Infect Immun; 2004 Dec; 72(12):7012-21. PubMed ID: 15557624
[TBL] [Abstract][Full Text] [Related]
4. Salmonella Typhimurium strain expressing OprF-OprI protects mice against fatal infection by Pseudomonas aeruginosa.
Zhang M; Sun C; Gu J; Yan X; Wang B; Cui Z; Sun X; Tong C; Feng X; Lei L; Han W
Microbiol Immunol; 2015 Sep; 59(9):533-44. PubMed ID: 26249788
[TBL] [Abstract][Full Text] [Related]
5. Regulated Delayed
Su H; Liu Q; Wang S; Curtiss R; Kong Q
Theranostics; 2019; 9(12):3565-3579. PubMed ID: 31281498
[No Abstract] [Full Text] [Related]
6. Two Novel
Zhao X; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Sun K; Yang Q; Wu Y; Cheng A
Front Cell Infect Microbiol; 2017; 7():391. PubMed ID: 28929089
[TBL] [Abstract][Full Text] [Related]
7. Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge.
Huang C; Liu Q; Luo Y; Li P; Liu Q; Kong Q
Vaccine; 2016 Aug; 34(36):4285-92. PubMed ID: 27423383
[TBL] [Abstract][Full Text] [Related]
8. Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains.
Chen H; Schifferli DM
Infect Immun; 2000 Jun; 68(6):3129-39. PubMed ID: 10816454
[TBL] [Abstract][Full Text] [Related]
9. A Live
Aguilera-Herce J; García-Quintanilla M; Romero-Flores R; McConnell MJ; Ramos-Morales F
mSphere; 2019 Apr; 4(2):. PubMed ID: 30996108
[No Abstract] [Full Text] [Related]
10. Enhanced immunogenicity in the murine airway mucosa with an attenuated Salmonella live vaccine expressing OprF-OprI from Pseudomonas aeruginosa.
Arnold H; Bumann D; Felies M; Gewecke B; Sörensen M; Gessner JE; Freihorst J; von Specht BU; Baumann U
Infect Immun; 2004 Nov; 72(11):6546-53. PubMed ID: 15501786
[TBL] [Abstract][Full Text] [Related]
11. Genetic engineering of Francisella tularensis LVS for use as a novel live vaccine platform against Pseudomonas aeruginosa infections.
Robinson CM; Kobe BN; Schmitt DM; Phair B; Gilson T; Jung JY; Roberts L; Liao J; Camerlengo C; Chang B; Davis M; Figurski L; Sindeldecker D; Horzempa J
Bioengineered; 2015; 6(2):82-8. PubMed ID: 25617059
[TBL] [Abstract][Full Text] [Related]
12. Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine.
Kang HY; Srinivasan J; Curtiss R
Infect Immun; 2002 Apr; 70(4):1739-49. PubMed ID: 11895935
[TBL] [Abstract][Full Text] [Related]
13. Enterobacterial common antigen mutants of Salmonella enterica serovar Typhimurium establish a persistent infection and provide protection against subsequent lethal challenge.
Gilbreath JJ; Colvocoresses Dodds J; Rick PD; Soloski MJ; Merrell DS; Metcalf ES
Infect Immun; 2012 Jan; 80(1):441-50. PubMed ID: 22025511
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a highly attenuated Salmonella enterica serovar Typhimurium mutant strain.
Tang IK; Ji DD; Chou CF; Lin HC; Liao CL; Sytwu HK; Wang JJ; Liu YT
J Microbiol Immunol Infect; 2002 Dec; 35(4):229-35. PubMed ID: 12542248
[TBL] [Abstract][Full Text] [Related]
15. Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.
Tennant SM; Schmidlein P; Simon R; Pasetti MF; Galen JE; Levine MM
Infect Immun; 2015 Dec; 83(12):4504-12. PubMed ID: 26351285
[TBL] [Abstract][Full Text] [Related]
16. Attenuated
Liu Q; Li P; Luo H; Curtiss R; Kong Q
Virulence; 2019 Dec; 10(1):82-96. PubMed ID: 31874075
[No Abstract] [Full Text] [Related]
17. Stable expression of Shigella sonnei form I O-polysaccharide genes recombineered into the chromosome of live Salmonella oral vaccine vector Ty21a.
Dharmasena MN; Hanisch BW; Wai TT; Kopecko DJ
Int J Med Microbiol; 2013 Apr; 303(3):105-13. PubMed ID: 23474241
[TBL] [Abstract][Full Text] [Related]
18. Live attenuated Salmonella Typhimurium with monophosphoryl lipid A retains ability to induce T-cell and humoral immune responses against heterologous polysaccharide of Shigella flexneri 2a.
Liu Q; Su H; Bian X; Wang S; Kong Q
Int J Med Microbiol; 2020 Jul; 310(5):151427. PubMed ID: 32654768
[TBL] [Abstract][Full Text] [Related]
19. Recombinant attenuated Salmonella Typhimurium with heterologous expression of the Salmonella Choleraesuis O-polysaccharide: high immunogenicity and protection.
Zhao X; Dai Q; Zhu D; Liu M; Chen S; Sun K; Yang Q; Wu Y; Kong Q; Jia R
Sci Rep; 2017 Jul; 7(1):7127. PubMed ID: 28754982
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Salmonella enterica serovar Typhimurium and Choleraesuis slyA mutant strains for use in live attenuated oral vaccines.
Haneda T; Okada N; Kikuchi Y; Takagi M; Kurotaki T; Miki T; Arai S; Danbara H
Comp Immunol Microbiol Infect Dis; 2011 Sep; 34(5):399-409. PubMed ID: 21840053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
